Hims and Hers is airing an ad about its copycat GLP-1 drugs during Sunday’s Super Bowl. Critics say it violates FDA rules.
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
The removal of FDA guidance on clinical trial diversity and related anti–diversity, equity, and inclusion (DEI) actions may ...
The disappearance of certain CDC data and guidelines from its website last week could hinder the ability or willingness of ...
Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
As critics contend it is setting a dangerous precedent, legislation is advancing through the Illinois General Assembly that ...
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Some food labels designed to nudge Americans toward healthier food choices can have the opposite effect, new University of ...
One day in 2022, a logger visited Gblorso Town and asked elders to prospect their forest. The elders consented, and Clarence Massquoi found marketable timber species there, promising to return soon.
PDS Biotechnology (PDSB) reaffirmed the Company’s guidance of initiating its VERSATILE-003 Phase 3 clinical trial of Versamune HPV plus ...